fda label semaglutide naion warning 2025 The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added fda label semaglutide naion warning

He now specializes in evidence-based weight management, including GLP-1/GIP therapies (semaglutide & tirzepatide)

While semaglutide does not have direct CNS stimulant effects, some patients report fatigue or mood alterations

Known for its bright yellow color and bitter taste, it has been used for over 3,000 years in traditional medicine to treat infections, diarrhea, and metabolic issues

Alcohol interacts differently with each alternative

The recommended starting dosage of the injectable version of semaglutide for diabetes is 0.25 mg injected subcutaneously once a week for 4 weeks, followed by 0.5 mg once a week for 4 weeks